S112 Circulating biomarkers and outcome from a randomised phase II trial of sunitinib vs everolimus for patients with metastatic renal cell carcinoma M. H. Voss et al.S120 Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma M.